LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 78,181 Value ($000) $78 Avg Close $1.10 Range $0.84 - $1.56
Q1 2024
Shares 69,709 Value ($000) $103 Avg Close $1.13 Range $0.84 - $1.61
Q4 2023
Shares 68,754 Value ($000) $75 Avg Close $1.10 Range $0.90 - $1.37
Q3 2023
Shares 68,754 Value ($000) $81 Avg Close $1.36 Range $1.15 - $1.54
Q2 2023
Shares 68,754 Value ($000) $97 Avg Close $1.38 Range $1.24 - $1.57
Q4 2021
Shares 49,379 Value ($000) $121 Avg Close $2.34 Range $1.80 - $2.71
Q3 2021
Shares 16,627 Value ($000) $42 Avg Close $2.57 Range $2.26 - $2.90
Q2 2021
Shares 50,559 Value ($000) $144 Avg Close $2.59 Range $2.14 - $3.00